Cannabis Stock News Daily Roundup May 1


Panaxia Pharmaceutical Industries Israel and pharmaceutical company Rafa signed a collaboration agreement with PlantEXT Ltd., an Israeli-Canadian medical cannabis company. Under the agreement, the parties will co-develop the next generation of medical cannabis products intended for patients suffering from Inflammatory Bowel Disease, and who are authorized to receive treatment with medical cannabis.

Story continues below

Khiron Life Sciences (TSXV: KHRN) (OTCQB: KHRNF) (Frankfurt: A2JMZC) reported its financial results for the year ended December 31, 2018. The company achieved first sales during the fourth quarter of fiscal 2018, with sales totaling C$891,677. Operating costs were consistent with management expectations and totaled to C$20.09 million.

Curaleaf Holdings (CSE: CURA) (OTCQX: CURLF) has signed a definitive agreement to acquire the state-regulated cannabis business of Cura Partners, owners of the Select brand, in an all-stock transaction valued at C$1.27 billion or US$948.8 million.

Dixie Brands (CSE: DIXI.U) (OTC: DXBRF) (Frankfurt: 0QVhas announced its financial results for the year ended December 31, 2018. Revenue was $5.79 million in fiscal 2018, an increase of 73% from around $3.34 million of revenue in 2017. Revenue was $1.59 million in the fourth quarter of 2018, compared to $709,677 a year earlier, an increase of 123%. Net loss attributable to the company was $21.24 million in 2018, compared to $4.34 million the previous year.

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (US: TGODFannounced the opening of its second legal cannabis retail store in Jamaica –  in conjunction with Epican Medicinals. Located on Montego Bay’s “Hip Strip”, the flagship location will open for business on May 4Montego Bay is a popular tourist destination and Jamaica’s second largest city. It is also a major port of call for cruise ships, a destination for duty-free shopping and home to the country’s largest airport.

Planet 13 Holdings (CSE: PLTH) (OTCQB: PLNHF) announced financial results for the three and 12-month periods ended December 31, 2018. Revenues were $8.3 million for the fourth quarter of 2018, versus $3.4 million for the quarter ended December 31, 2017, an increase of 145%. Quarterly net loss was $4.0 million, versus a profit of $259,493 for the same quarter of 2017.

Flower One Holdings (CSE: FONE) (OTCQB: FLOOF) reported its financial and operating results for the fourth quarter and year ended December 31, 2018. Revenue for the fourth quarter and the fiscal year was $130,969 and the company recorded a loss of $5.28 million. For the fiscal year, Flower One recorded a loss of $12.45 million. The company was incorporated on December 18, 2017, and as such, no comparable information is available for the fourth quarter and full-year periods ended December 31, 2017.

An ad to help with our costs